GemPharmatech (SH:688046) Zheng Quan Zhi Xing·2025-05-28 10:44Meeting Overview - The shareholders' meeting of Jiangsu Jicui Yaokang Biotechnology Co., Ltd. was held on May 28, 2025, in Nanjing [1] - A total of 38 ordinary shareholders attended, holding 215,128,854 voting rights, which accounts for 52.8039% of the company's total voting rights [1] Voting Results - All proposed resolutions were approved with significant majority votes, including: - Resolution 1: 99.8955% in favor, 0.0998% against, and 0.0047% abstained [1] - Resolution 2: 99.8957% in favor, 0.0995% against, and 0.0048% abstained [1] - Resolution 3: 99.8955% in favor, 0.0998% against, and 0.0047% abstained [1] - Resolution 4: 99.8938% in favor, 0.1014% against, and 0.0048% abstained [2] Shareholder Composition - The meeting included various categories of shareholders, with a notable presence of those holding less than 5% of shares, which accounted for 98.7830% in favor of the resolutions [3] - The voting rights of shareholders with a market value below 500,000 were also represented, indicating broad participation [3] Legal Compliance - The meeting's procedures and voting processes were confirmed to be in compliance with the Company Law and relevant regulations, ensuring the legality and validity of the resolutions passed [3][4]